Cutting-edge artificial intelligence tools are transforming biomedical research, featuring prominently in oncology and drug discovery. Researchers have developed AI models that predict hematologic toxicity in cervical cancer patients and detailed comprehensive mouse brain maps identifying 1,300 brain regions using transformer-based models akin to ChatGPT. Furthermore, companies like Twist Bioscience and Element Biosciences expanded targeted sequencing collaborations, while Insilico Medicine unveiled the LEGION workflow for vast chemical space coverage and competitive advantage in drug discovery. These innovations signal a paradigm shift in precision medicine and therapeutic development.